Study for novel coronavirus pneumonia (COVID-19) patients etiology and immune response and guidance for vaccine design

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000030950

Enrollment

Unknown

Registered

2020-03-19

Start date

2020-02-10

Completion date

Unknown

Last updated

2020-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

the patients of 2019 new coronavirus pneumonia:None

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients diagnosed with new coronavirus pneumonia

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Nucleic acid;	—

Countries

China

Contacts

Public ContactLiujie

West China Hospital of Sichuan University

liudr@outlook.com+86 18980606533

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026